Literature DB >> 18598302

Carvedilol overdose with quantitative confirmation.

Nicole C Bouchard1, Jenice Forde, Robert S Hoffman.   

Abstract

Carvedilol is a non-selective beta-adrenoreceptor antagonist that is also an antagonist at the alpha(1)-adrenoreceptor. This unique pharmacological effect may produce a different toxicodynamic profile compared to other beta-adrenoreceptor antagonists. Only one previous case of carvedilol overdose has been reported. Here, we report massive carvedilol ingestion confirmed by quantitative analysis. The case report deals with an 84-year-old man who chewed a total of 60 (6.25 mg) tablets and rapidly developed symptoms. Vital signs on presentation were systolic blood pressure 70 mmHg; heart rate 45 beats/min.; respirations 18 breaths/min.; temperature 37 degrees . The electrocardiogram showed a junctional rhythm at 49 beats/min. The patient was treated with normal saline boluses, repeated glucagon boluses (2-3 mg each) and a dopamine infusion. At 14 hr after ingestion, he was weaned off vasopressors and was in a normal sinus rhythm. Quantitative confirmation showed a carvedilol serum concentration of 472 ng/ml (steady-state concentration 8.5 ng/ml during 6.25 mg twice daily dosing). Despite its unique pharmacological properties, the clinical manifestations of carvedilol overdose appear similar to other beta-adrenoreceptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598302     DOI: 10.1111/j.1742-7843.2008.00269.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  2 in total

1.  Persistent wheezing caused by carvedilol overdose in a non-asthmatic man.

Authors:  Misuzu Nakanishi; Akira Kuriyama; Mutsuo Onodera
Journal:  Acute Med Surg       Date:  2019-12-14

2.  Severe carvedilol toxicity without overdose - caution in cirrhosis.

Authors:  Satish Maharaj; Karan Seegobin; Julio Perez-Downes; Belinda Bajric; Simone Chang; Pramod Reddy
Journal:  Clin Hypertens       Date:  2017-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.